Skip Navigation


Rheumatology Advance Access originally published online on March 20, 2008
Rheumatology 2008 47(5):733-734; doi:10.1093/rheumatology/ken075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/733    most recent
ken075v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hatemi, G.
Right arrow Articles by Yazici, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatemi, G.
Right arrow Articles by Yazici, H.
Related Collections
Right arrow Vasculitis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Purified protein derivative reaction is not augmented in Behçet's syndrome patients

G. Hatemi1, M. Melikoglu1, N. Sut2 and H. Yazici1

1Rheumatology Division, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul and 2Department of Biostatistics, Medical School, Trakya University, Edirne, Turkey.

Correspondence to: G. Hatemi, Cerrahpasa Tip Fakultesi, Ic Hastaliklari ABD, 34300 Aksaray, Istanbul, Turkey. E-mail: gulenhatemi@yahoo.com

The first 10% of the full text of this article appears below.

SIR, In a recent position paper about the emerging role of TNF-{alpha} antagonists in managing Behçet's syndrome (BS), the importance of screening BS patients for latent tuberculosis before starting treatment with these agents has been emphasized [1]. This is especially important since in geographies where BS is endemic, the prevalence of tuberculosis is also relatively high. Guidelines recommend screening all patients with a tuberculin test and chest X-ray before starting treatment with TNF-{alpha} antagonists [2]. Case reports suggest that . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?